Compared before and after COVID-19 wave phases, the number of AS patients with ASDAS-ESR and ASDAS-CRP < 1.3 were decreased but without significantly (60 vs. 52, p = 0.088; 68 vs. 63, p = 0.368) (Table 4). The gene discussed is CRP; the disease is COVID-19.